Novo Nordisk A/S
The Open Rank Scientist role at Novo Nordisk Research Centre China supports in vivo pharmacology for target validation and early pipeline development in cardiometabolic diseases. The position involves designing and executing rodent pharmacology studies, analyzing data, and collaborating cross-functionally to inform drug discovery decisions. The role requires a Ph.D. in a relevant field and demonstrated experience in in vivo pharmacology and cardiometabolic diseases.
Headquarters
Alle, Central Jutland, Denmark
Company Size
10001+ employees
Founded
1923
Novo Nordisk is a leading global healthcare company founded in 1923 and headquartered in Denmark, with the stated purpose of driving change to defeat diabetes and other serious chronic diseases. It researches, develops, manufactures and markets pharmaceutical products and medical devices across diabetes care, obesity, haemophilia, growth disorders and other endocrine conditions, and is widely known for its insulin and GLP‑1 therapies. Combining extensive R&D, large‑scale manufacturing and global commercial reach, Novo Nordisk emphasizes patient‑centred care, access programs and sustainability in its work to improve outcomes for people with chronic disease.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Novo Nordisk A/S.
Novo Nordisk A/S didn’t post a salary, so this is our estimate from similar listings.
18% below the average for this role
Senior Principal Scientist
State of Indiana
Associate Principal Scientist, In Vivo Pharmacology
MSD
Principal Scientist In vivo Immunology
Sanofi
Principal Scientist - Large Animal Pharmacology
State of Indiana
Associate Principal Scientist, In Vivo Pharmacology
Merck & Co., Inc.
Associate Principal Scientist, In Vivo Pharmacology
Merck & Co., Inc.